Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05254834 · ClinicalTrials.gov registry record
The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
A clinical trial of Cancer, sponsored by Freenome Holdings.
- Completed
- Registry status
- 7,435
- Enrollment target
- 20
- Study locations
NCT05254834 is a study of Cancer that has completed, run by Freenome Holdings. The registered enrollment target is 7,435 participants, above the 3,479-participant average among 615 other Cancer trials with a reported enrollment target (114% higher). The trial reports 20 study locations across 6 states.
The verdict
NCT05254834, a study of Cancer, has completed, sponsored by Freenome Holdings.
- COMPLETED
- Registry status
- 7,435 participants
- Enrollment target
- 20
- Study locations
Study Summary
This protocol is a case-control, multicenter, diagnostic study to collect blood samples to support the development of blood-based screening tests for multiple cancers.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Freenome Test
Study Locations (20)
California
- John Muir Health - Concord
- Carbon Health - Corona
- Miller Bioconnect - El Cajon
- Gastroenterology and Liver Institute - Escondido
- Women's Cancer Network - Fresno
- San Diego Clinical Trials - La Mesa
- Urology Alliance Clinical Research - Los Angeles
- Mercy Cancer Center - Merced
- Pomona Valley Hospital Medical Center/Cancer Care Center - Pomona
- St. Mary's Medical Center - San Francisco
- Dominican Hospital Dignity Health - Santa Cruz
- Stockton Hematology Oncology - Stockton
- Torrance Memorial Physician Network - Cancer Care - Torrance
Alabama
- Central Alabama Research - Birmingham
- Alabama Oncology - Birmingham
Florida
- RecioMed Clinical Research - Boynton Beach
- Mid Florida Hematology & Oncology Center - Orange City
Arizona
- Honor Health - Scottsdale
Arkansas
- Highlands Oncology Group - Springdale
Connecticut
- Eastern CT Hematology and Oncology Associates - Norwich
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,435 participants |
| Start Date | 2022-02-15 |
| Est. Completion | 2025-07-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05254834
The ClinicalTrials.gov registry entry for NCT05254834 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7,435 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,479-participant average among 615 other Cancer trials with a reported enrollment target (114% higher). The listed sponsor is Freenome Holdings, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Freenome Test is the first listed.
NCT05254834 reports 20 study locations spanning 6 distinct geographic areas - top geographies include California, Alabama, Florida.
Frequently Asked Questions
What is clinical trial NCT05254834 about?
NCT05254834 is a clinical study titled "The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening". This protocol is a case-control, multicenter, diagnostic study to collect blood samples to support the development of blood-based screening tests for multiple cancers.
What is the current status of trial NCT05254834?
This trial is currently completed. The enrollment target is 7,435 participants. The study started on 2022-02-15. Estimated completion is 2025-07-12.
What conditions does trial NCT05254834 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT05254834?
The interventions under investigation include: Freenome Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05254834?
This trial is sponsored by Freenome Holdings, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05254834 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.